Unknown

Dataset Information

0

Pentablock copolymer dexamethasone nanoformulations elevate MYOC: in vitro liberation, activity and safety in human trabecular meshwork cells.


ABSTRACT:

Aim

The aim of this study is to examine the elevation of MYOC in long-term treatment of human trabecular meshwork (HTM) cells using dexamethasone (DEX) encapsulated pentablock (PB) copolymer-based nanoparticles (NPs) (DEX-PB-NPs).

Materials & methods

PB copolymers and DEX-PB-NPs were synthesized and characterized using nuclear magnetic resonance, gel permeation chromatography, and X-ray diffraction analyses. MYOC levels secreted from HTM cells were measured by western blot (WB) analysis.

Results

DEX-PB-NPs were formulated in the size range of 109 ± 3.77 nm (n = 3). A long term DEX release from the NPs was observed over three months. Cell viability and cytotoxicity were not affected up to 12 weeks of treatment with PB-copolymer or DEX-PB-NPs. WB data from five HTM cell strains showed that MYOC levels increased by 5.2 ± 1.3, 7.4 ± 4.3, and 2.8 ± 1.1-fold in the presence of DEX-PB-NPs compared with 9.2 ± 3.8, 2.2 ± 0.5, and 1.5 ± 0.3-fold at 4, 8 and 12 weeks in control-DEX treatment group, respectively (n = 5). Based on the decline in MYOC levels after withdrawal of DEX from control wells, DEX-PB-NPs released the DEX for at least 10 weeks.

Conclusion

The treatment of HTM cells using DEX-PB-NPs were analyzed in this study. The in vitro cell-based system developed here is a valuable tool for determining the safety and effects of steroids released from polymeric NPs.

SUBMITTER: Agrahari V 

PROVIDER: S-EPMC5551562 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pentablock copolymer dexamethasone nanoformulations elevate MYOC: in vitro liberation, activity and safety in human trabecular meshwork cells.

Agrahari Vibhuti V   Li Guorong G   Agrahari Vivek V   Navarro Iris I   Perkumas Kristin K   Mandal Abhirup A   Stamer W Daniel WD   Mitra Ashim K AK  

Nanomedicine (London, England) 20170731 16


<h4>Aim</h4>The aim of this study is to examine the elevation of MYOC in long-term treatment of human trabecular meshwork (HTM) cells using dexamethasone (DEX) encapsulated pentablock (PB) copolymer-based nanoparticles (NPs) (DEX-PB-NPs).<h4>Materials & methods</h4>PB copolymers and DEX-PB-NPs were synthesized and characterized using nuclear magnetic resonance, gel permeation chromatography, and X-ray diffraction analyses. MYOC levels secreted from HTM cells were measured by western blot (WB) an  ...[more]

Similar Datasets

| S-EPMC4509060 | biostudies-literature
| S-EPMC11402775 | biostudies-literature
| S-EPMC10784477 | biostudies-literature
| S-EPMC11430611 | biostudies-literature
2015-01-24 | GSE65240 | GEO
2012-10-01 | GSE37474 | GEO
| S-EPMC3790389 | biostudies-literature
| S-EPMC3536900 | biostudies-literature
2018-12-20 | GSE124114 | GEO
| S-EPMC9358186 | biostudies-literature